- Home
- EQ vs OPRX Comparison
EQ vs OPRX Comparison
Compare EQ & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQ | OPRX |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.0M | 120.1M |
| IPO Year | 2018 | 2008 |
Fundamental Metrics
Financial Performance| Metric | EQ | OPRX |
|---|---|---|
| Price | $2.36 | $4.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $8.00 | ★ $16.67 |
| AVG Volume (30 Days) | 302.2K | ★ 377.1K |
| Earning Date | 05-25-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | N/A | ★ 0.27 |
| Revenue | $41,095,000.00 | ★ $109,429,000.00 |
| Revenue This Year | N/A | $3.88 |
| Revenue Next Year | N/A | $8.34 |
| P/E Ratio | ★ N/A | $23.72 |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $0.29 | $5.54 |
| 52 Week High | $2.70 | $22.25 |
Technical Indicators
Market Signals| Indicator | EQ | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 62.86 | 28.69 |
| Support Level | $1.60 | N/A |
| Resistance Level | $2.49 | $7.23 |
| Average True Range (ATR) | 0.16 | 0.41 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 91.46 | 11.78 |
Price Performance
Historical ComparisonAbout EQ Equillium Inc.
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.